Inventor · disambiguated record
Michael Clinton Koons
Also filed as: KOONS MICHAEL · KOONS MICHAEL CLINTON
8 granted patents·3 pending applications·208 citations·filing 2012–2025
89Inventor score
Files withSUNOVION PHARMACEUTICALS INC5CYNAPSUS THERAPEUTICS INC3AQUESTIVE THERAPEUTICS INC2BRYSON NATHAN JOHN1
Top patents by PatentIndex Score
11 records- 0198US9427412B2Sublingual filmsCYNAPSUS THERAPEUTICS INC·Filed 2016·Granted Aug 30, 2016·67 cites·23 claims
- 0295US10285953B2Sublingual filmsSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted May 14, 2019·17 cites·22 claims
- 0395US9283219B2Sublingual filmsCYNAPSUS THERAPEUTICS INC·Filed 2014·Granted Mar 15, 2016·23 cites·29 claims
- 0495US8846074B2Sublingual filmsCYNAPSUS THERAPEUTICS INC·Filed 2013·Granted Sep 30, 2014·31 cites·19 claims
- 0595US8414922B2Sublingual filmsBRYSON NATHAN JOHN·Filed 2012·Granted Apr 9, 2013·67 cites·23 claims
- 0686US10449146B2Methods of treating parkinson's disease by administration of apomorphine to an oral mucosaSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Oct 22, 2019·2 cites·13 claims
- 0783US10959943B2Methods of treating Parkinson's disease by administration of apomorphine to an oral mucosaSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Mar 30, 2021·1 cites·52 claims
- 0876US11419769B2Sublingual filmsSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Aug 23, 2022·0 cites·21 claims
- 0966US2021205208A1Methods of treating parkinson's disease by administration of apomorphine to an oral mucosaSUNOVION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1059US2023130055A1Pharmaceutical compositions with enhanced stability profilesAQUESTIVE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1148US2025281392A1Topical delivery of epinephrine and prodrug compositionsAQUESTIVE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Clinton Koons files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →